Enhanced Sensitivity for Detection of HIV-1 p24 Antigen by a Novel Nuclease-Linked Fluorescence Oligonucleotide Assay
Open Access
- 27 April 2015
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (4) , e0125701
Abstract
The relatively high detection limit of the Enzyme-linked immunosorbent assay (ELISA) prevents its application for detection of low concentrations of antigens. To increase the sensitivity for detection of HIV-1 p24 antigen, we developed a highly sensitive nuclease-linked fluorescence oligonucleotide assay (NLFOA). Two major improvements were incorporated in NLFOA to amplify antibody-antigen interaction signals and reduce the signal/noise ratio; a large number of nuclease molecules coupled to the gold nanoparticle/streptavidin complex and fluorescent signals generated from fluorescent-labeled oligonucleotides by the nuclease. The detection limit of p24 by NLFOA was 1 pg/mL, which was 10-fold more sensitive than the conventional ELISA (10 pg/mL). The specificity was 100% and the coefficient of variation (CV) was 7.8% at low p24 concentration (1.5 pg/mL) with various concentrations of spiked p24 in HIV-1 negative sera. Thus, NLFOA is highly sensitive, specific, reproducible and user-friendly. The more sensitive detection of low p24 concentrations in HIV-1-infected individuals by NLFOA could allow detection of HIV-1 infections that are missed by the conventional ELISA at the window period during acute infection to further reduce the risk for HIV-1 infection due to the undetected HIV-1 in the blood products. Moreover, NLFOA can be easily applied to more sensitive detection of other antigens.Keywords
This publication has 51 references indexed in Scilit:
- Failures in the Detection of HIV p24 Antigen With the Determine HIV-1/2 Ag/Ab Combo Rapid TestThe Journal of Infectious Diseases, 2012
- Two types of nanoparticle-based bio-barcode amplification assays to detect HIV-1 p24 antigenVirology Journal, 2012
- HIV Screening via Fourth-Generation Immunoassay or Nucleic Acid Amplification Test in the United States: A Cost-Effectiveness AnalysisPLOS ONE, 2011
- Catalase-coupled gold nanoparticles: Comparison between the carbodiimide and biotin–streptavidin methodsActa Biomaterialia, 2011
- Cost-Effectiveness of Nucleic Acid Amplification Tests for Identifying Acute HIV InfectionsJournal of Clinical Microbiology, 2011
- Cost-Effectiveness of Pooled Nucleic Acid Amplification Testing for Acute HIV Infection after Third-Generation HIV Antibody Screening and Rapid Testing in the United States: A Comparison of Three Public Health SettingsPLOS Medicine, 2010
- Characterization of Immune Responses to Capsid Protein p24 of Human Immunodeficiency Virus Type 1 and Implications for DetectionClinical and Vaccine Immunology, 2010
- Nanoparticle‐Based Immunoassays for Sensitive and Early Detection of HIV‐1 Capsid (p24) AntigenThe Journal of Infectious Diseases, 2010
- Nanoparticles for detection and diagnosisAdvanced Drug Delivery Reviews, 2010
- Evaluation of the use of chromogenic and fluorogenic substrates in solid-phase enzyme linked immunosorbent assays (ELISA)Biologicals, 1990